RA
CLPT icon

Royce & Associates’s ClearPoint Neuro CLPT Stock Holding History

Royce & Associates’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,205
Closed -$199K – 881
2024
Q1 		$199K Sell
29,205
-23,860
-45% -$167K ﹤0.01% 834
2023
Q4 		$360K Buy
+53,065
New +$300K ﹤0.01% 813
2022
Q1 		– Sell
-17,700
Closed -$199K – 966
2021
Q4 		$199K Sell
17,700
-596,807
-97% -$8.93M ﹤0.01% 946
2021
Q3 		$10.9M Buy
614,507
+523,607
+576% +$9.82M 0.08% 385
2021
Q2 		$1.74M Buy
90,900
+35,800
+65% +$692K 0.01% 780
2021
Q1 		$1.17M Buy
+55,100
New +$1.18M 0.01% 836

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return